An evidence-based guide to how ashwagandha (Withania somnifera) affects the stress response and cognitive performance — including the nuances most articles leave out.
Ashwagandha reliably lowers the stress hormone cortisol — clinical trials show reductions of roughly 11–33% over 30–90 days, with most landing in the 14–28% range. Its effects on cognition (memory, attention, executive function) are real but more modest, and the best current evidence suggests they are largely a downstream consequence of reduced stress rather than a direct "smart-drug" action on the brain. Standardised root extracts (KSM-66, Sensoril) at 300–600 mg/day for at least 8 weeks are what the research supports. It is generally well tolerated for up to about three months, but it is not suitable for everyone — pregnancy, thyroid disease, autoimmune conditions and certain medications are firm cautions.
Most articles blur two separate questions into one. It is worth pulling them apart:
Measured objectively through serum cortisol, and subjectively through validated questionnaires like the Perceived Stress Scale (PSS) and the Hamilton Anxiety Rating Scale (HAM-A).
Measured through tests of memory (episodic and working), attention, reaction time, executive function and information processing speed.
Key insight: These are related but not identical. Ashwagandha performs strongly on one objective stress marker while the picture for how stressed people feel — and for cognition — is more textured. Keeping the two apart is the single most useful habit when reading the literature.
Ashwagandha's active compounds are withanolides — a family of steroidal lactones that includes withaferin A, withanolide A, and the sitoindosides. They act on several targets at once, which is why the herb is classed as an adaptogen (a substance that helps the body normalise its stress response rather than simply sedating or stimulating).
The central pathway is the hypothalamic–pituitary–adrenal (HPA) axis — the hormonal cascade that governs cortisol release:
The same receptor family targeted by benzodiazepines, but without dependence. Helps explain the calming and sleep-supportive effects. The species name somnifera literally means "sleep-inducing".
Withanolides are structurally similar to human steroid hormones, which is why the herb can nudge thyroid and reproductive hormones — a double-edged property covered in the safety section.
Anti-inflammatory pathway. Withanolides inhibit NF-κB and activate Nrf2, producing antioxidant and anti-inflammatory effects that complement the HPA-axis action.
Multi-target action across the HPA axis, GABA system, and inflammatory pathways classifies ashwagandha as a true adaptogen — normalising the stress response rather than simply sedating or stimulating.
This is where ashwagandha's evidence is strongest. Multiple randomised, double-blind, placebo-controlled trials have measured serum cortisol directly rather than relying only on self-report.
| Study | Extract & Dose | Duration | Serum Cortisol Change |
|---|---|---|---|
| Chandrasekhar et al., 2012 | KSM-66, 300 mg × 2/day | 60 days | −27.9% |
| Auddy et al., 2008 | Sensoril, 125 mg/day | 60 days | −24.2% |
| Salve/Lopresti et al., 2019 | KSM-66, 240–600 mg/day | 60 days | Significant reduction in morning cortisol |
| Meta-Analysis | Studies / n | Key Stress Outcomes |
|---|---|---|
| 2024 Systematic Review (9 RCTs) | 558 patients | PSS −4.72; HAM-A −2.19; serum cortisol −2.58 µg/dL |
| Albalawi et al., 2025 ("Dual Impact") | 7 cortisol / 6 PSS studies; n = 488 | Cortisol −1.16 µg/dL (p < 0.001); perceived stress not significant |
The consistency here is the point. For a botanical supplement, a directly measured hormonal biomarker moving reproducibly across independent trials is unusual and clinically meaningful.
Here is the finding that top-ranking articles almost universally skip. In 2025, a systematic review and meta-analysis (Albalawi et al.) deliberately separated the two questions and found a striking dissociation:
−1.16 µg/dL
p < 0.001 — Statistically significant
Not Significant
SMD −0.355, p = 0.40
Lowering the hormone and changing the subjective experience of stress are not guaranteed to be the same thing. Individual response varies widely, and the biomarker is more reliable than the feeling.
Practically, this means two people can both show a textbook cortisol drop while only one feels calmer. If you try ashwagandha, judge it on how you actually feel and function over 8+ weeks — not on the assumption that a lab number automatically translates to lived experience.
Cognitive research is younger and smaller than the stress research, but it is growing and increasingly positive.
| Study | Population | Extract & Dose | Cognitive Findings |
|---|---|---|---|
| Choudhary et al., 2017 | Adults with mild cognitive impairment | KSM-66, 300 mg × 2/day, 8 wks | Improved memory, executive function, attention, processing speed |
| Leonard et al., 2024 (Nutrients) | Healthy young adults | Liposomal ashwagandha, 225 mg, acute + 30 days | Improved memory, attention, vigilance, executive function; reduced tension and fatigue |
| Lopresti et al., 2024 (J. Psychoactive Drugs) | Adults with cognitive/energy/mood complaints | Root extract, 6 months | Episodic memory (p = .026), working memory (p = .027), attention accuracy (p < .001) |
The domains that come up repeatedly: episodic memory, working memory, attention and executive function. The 2024 Nutrients trial is notable for showing benefits in healthy young adults, not just clinical or elderly populations — and even for showing some acute (same-day) effects.
This is the honest, differentiating question — and the answer requires care.
Ashwagandha's cognitive benefits are largely secondary to its stress- and sleep-related effects, rather than a direct nootropic action on memory circuits. Chronic stress and elevated cortisol measurably impair attention, working memory and executive function; by recalibrating the HPA axis, improving sleep and lowering inflammation, ashwagandha removes a drag on cognition rather than acting as a direct cognitive accelerant.
Not all ashwagandha is equivalent. The withanolide concentration of raw powder can range from under 1% to over 4% depending on soil, harvest and processing — which makes generic bulk powder unpredictable. Standardised extracts solve this.
| Feature | KSM-66 | Sensoril | Shoden |
|---|---|---|---|
| Plant Part | Root Only | Root + Leaf | Root + Leaf |
| Withanolides | ~5% | ~10% | ~35% |
| Typical Dose | 300–600 mg/day | 125–250 mg/day | 120 mg/day |
| Best-Evidenced For | Stress, cortisol, cognition, testosterone (men) | Sleep, relaxation, anxiety | Sleep |
| Clinical Trials | ~24–30 RCTs | ~15 RCTs | Fewer |
| Liver-Safety Note | Lower Risk — Low withaferin A (root only) | Caution — Higher withaferin A (leaf) | Caution — Higher withaferin A (leaf) |
300–600 mg/day of a root extract standardised to at least 5% withanolides is the best-supported protocol.
Consistency matters more than clock time. Morning dosing suits daytime stress; evening (often Sensoril) suits sleep. Split dosing (300 mg AM + 300 mg PM) matches many clinical protocols.
Improves tolerability and reduces the mild GI upset some people report.
Independent testing has found some products deliver well under their labelled withanolide content. Look for a Certificate of Analysis or third-party testing.
Ashwagandha is not an acute intervention. Its mechanism — recalibrating the HPA axis — takes weeks.
Week 0
Start
Weeks 1–2
"Nothing"
No noticeable change
Weeks 3–4
First Subtle Signs
Calming / sleep changes
Weeks 6–8
Cortisol Measurable
Cognition builds
Weeks 8–12
Peak Effects
Stress, sleep & cognition
If you're going to trial it, commit to at least 8 weeks before judging. Abandoning it at day 10 because "nothing happened" is the most common way people wrongly conclude it doesn't work.
Ashwagandha is generally well tolerated for up to about three months, with mild gastrointestinal upset the most common complaint. But the "natural = harmless" framing is wrong, and here are the points that deserve genuine attention.
There are documented (though rare) case reports of ashwagandha-associated liver injury. The mechanism appears to involve withanone and withaferin A (both concentrated in the leaf), which can deplete glutathione, the liver's key protective antioxidant.
Paracetamol (acetaminophen) is detoxified through the same glutathione pathway. In theory, combining high-dose ashwagandha with regular paracetamol could place additive strain on the liver. Given how routinely paracetamol is taken in the UK, this is a sensible interaction to be aware of — and a strong argument for choosing root-only extracts (KSM-66), which contain negligible withaferin A. Statins and other liver-metabolised drugs warrant the same caution.
Ashwagandha can raise T3 and T4 and lower TSH. That may be beneficial in subclinical hypothyroidism, but it is a real risk in hyperthyroidism or Graves' disease, and it can interfere with thyroid medication dosing.
This article is for information only and is not medical advice. If you take prescription medication or have a health condition, speak to your GP or pharmacist before starting ashwagandha.
Ashwagandha is sold in the UK as a food supplement, not a licensed medicine, so it is not assessed for efficacy the way a drug would be. It remains widely available in health food shops and online retailers.
The wider European picture is shifting. Denmark has banned ashwagandha following a national risk assessment that flagged potential thyroid and reproductive effects, and other EU member states have signalled they were influenced by that decision.
Regulatory scrutiny is likely to increase as liver-injury case reports are more widely cited. None of this makes the herb unsafe at sensible doses for healthy adults — but it is context worth knowing, and another reason to prioritise well-characterised, root-only extracts from transparent manufacturers.
Ashwagandha is one of the better-evidenced botanicals for the stress response, with a reproducible, directly-measured effect on cortisol that most supplements can't claim. Its cognitive benefits are real but more modest and appear to flow largely from reduced stress, better sleep and lower inflammation rather than from a direct nootropic mechanism.
300–600 mg/day
standardised root extract
At least 8 weeks
before
judging results
Judge on how you feel
not
just lab numbers
Respect the genuine contraindications — pregnancy, thyroid disease, autoimmune conditions, upcoming surgery and interacting medications (including, plausibly, regular paracetamol). Treated that way, it is a reasonable, evidence-based tool for stress-driven cognitive complaints — not a magic focus pill.
Last reviewed: 2026. Written for herbalnootropics.life — evidence-based, safety-first natural nootropics.
NeuroVera is like nothing you've ever tried before — based on a closely guarded formula designed to help support memory function. With its unique blend of extremely hard-to-source ingredients, NeuroVera helps potentially support memory function and overall brain health.
NeuroVera combines rare botanicals including Schisandra, Shilajit, and Lion's Mane Mushroom with proven nootropics like Bacopa and Ginkgo Biloba. This plant-based formula supports neurotrophin function, mental clarity, and healthy neural communication.
Affiliate link — we may earn a commission at no extra cost to you